| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Lsv Associates, LLC last filed a Form 4 in December 2021, as 10% Owner at ALXO.
Our model assigns Lsv Associates, LLC a strong insider score of 78/100, based on 4 past trades. Over a 12-month horizon, all 4 of those trades were profitable, with an average 12-month return of +62.2%.
At the last filing, the largest reported position was 285,956 shares of ALXO. Net of sales, the ALXO filings show accumulation of 205,973 shares.
Lsv Associates, LLC has 3 Form 4 filings on record from July 2020 to December 2021, all as 10% Owner at Alx Oncology (ALXO), 2020–2021.
The 34 reported transactions were 28 open-market sales, 4 conversions and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $7.6M and 2 sales worth about $6.0M.
The only open-market purchase was 400,000 shares of ALXO at an average $19.00 on July 21, 2020, about $7.6M.
The largest open-market sale was 145,637 shares of ALXO at an average $32.26 on December 10, 2021, about $4.7M. Twelve months later ALXO was down 65%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | ALXO Alx Oncology Holdings Inc | 10% Owner | Sell | 48,390 | $26.61 | $1,287,431.32 | -14.5% | -33.0% | -51.4% | |
| Dec 10, 2021 | ALXO Alx Oncology Holdings Inc | 10% Owner | Sell | 145,637 | $32.26 | $4,698,091.14 | -33.3% | -39.9% | -65.4% | |
| Jul 21, 2020 | ALXO Alx Oncology Holdings Inc | 10% Owner | Buy | 400,000 | $19.00 | $7,600,000.00 | -105.8% | - | - |